Tag Archives: NYSE:MRT

RBC Capital Remains a Hold on MedEquities Realty Trust (MRT)

RBC Capital analyst Michael Carroll reiterated a Hold rating on MedEquities Realty Trust (NYSE: MRT) on August 10 and set a price target of $10. The company’s shares closed on Friday at $9.96, close to its 52-week low of $9.67.

MedEquities Realty Trust (MRT) Receives a Buy from B.Riley FBR

B.Riley FBR analyst Bryan Maher reiterated a Buy rating on MedEquities Realty Trust (NYSE: MRT) today and set a price target of $12. The company’s shares opened today at $10.17. According to TipRanks.com, Maher is a 3-star analyst with an

Cantor Fitzgerald Reiterates Their Buy Rating on MedEquities Realty Trust (MRT)

Cantor Fitzgerald analyst Joseph France reiterated a Buy rating on MedEquities Realty Trust (NYSE: MRT) today and set a price target of $12. The company’s shares opened today at $10.96. France noted: “We are lowering our price target to $12

Cantor Fitzgerald Keeps a Buy Rating on MedEquities Realty Trust

In a report released today, Joseph France from Cantor Fitzgerald reiterated a Buy rating on MedEquities Realty Trust (NYSE: MRT), with a price target of $13. The company’s shares closed yesterday at $10.86. France noted: “We are reiterating our $13

MedEquities Realty Trust Receives a Buy from Cantor Fitzgerald

Cantor Fitzgerald analyst Joseph France maintained a Buy rating on MedEquities Realty Trust (NYSE: MRT) today and set a price target of $14. The company’s shares closed yesterday at $10.75. France wrote: “MRT reported in-line 4Q17 results and issued 2018

MedEquities Realty Trust Received its Third Buy in a Row

After KeyBanc and B.Riley FBR assigned a Buy rating to MedEquities Realty Trust in the last month, the company received another Buy, this time from Cantor Fitzgerald. Analyst Joseph France reiterated a Buy rating on MedEquities Realty Trust (NYSE: MRT)